The Quantellect read.As of Nov 19, 2026, 8 active firms cover Taylor Morn Home: 0 rate it Buy or better, 7 sit at Neutral, and 1 rate it Sell or worse, a neutral consensus. Targets span $49.00 to $95.00, a moderate spread. The average target of $71.67 sits 1% below the current $72.45. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $1.42 next quarter toward $6.41 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS8 active firms
Neutral
Strong Buy00%
Buy00%
Neutral788%
Sell113%
Strong Sell00%
Based on 8 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$71.67
-1.1% downside
Average target across 6 active firms as of Nov 19, 2026 vs $72.45 current
Highest Target$95.00
Average Target$71.67
Lowest Target$49.00
Detailed analyst forecasts for TMHC
Showing 1–8 of 8 named analysts shown · 8 active firms in the rating projection
As of Nov 19, 2026, 0 of 8 active firms rate TMHC a Buy (7 Neutral, 1 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
TMHC EPS & revenue forecast
EPS · NEXT QUARTER
$1.42
Range $1.30 – $1.54 · 5 analysts · -33% YoY
Next period, 5 analysts expect Taylor Morn Home to earn $1.42 a share (range $1.30 – $1.54), versus $2.11 a year earlier. Full-year consensus is $5.28, growing to $6.41 the year after.
REVENUE · NEXT QUARTER
$1.8B
Range $1.6B – $1.9B · 5 analysts · -16% YoY
Revenue is expected to reach $1.8B (range $1.6B – $1.9B), -16.5% year-over-year. Full-year consensus is $6.6B, rising to $7.2B next year.
Top analysts covering Taylor Morn Home
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on TMHC.
#1
Jay McCanless
Wedbush · Rank #13
Buy
$85.00+17.3% to target
Overall win rate
63%
+ Follow
#2
Mike Dahl
RBC Capital · Rank #195
Buy
$72.50+0.1% to target
Overall win rate
50%
+ Follow
#3
Matthew Bouley
Barclays · Rank #227
Neutral
$73.00+0.8% to target
Overall win rate
42%
+ Follow
#4
Rafe Jadrosich
B of A Securities · Rank #398
Neutral
$68.00-6.1% to target
Overall win rate
40%
+ Follow
#5
Buck Horne
Raymond James · Rank #407
Neutral
No targeton TMHC
Overall win rate
39%
+ Follow
TMHC stock forecast FAQ
What is TMHC's average 12-month price target?+
The 6 active firms with a live target average $71.67 for Taylor Morn Home over the next 12 months, ranging from a $95.00 high to a $49.00 low, as of Nov 19, 2026.
Is TMHC stock a Buy, Sell or Neutral right now?+
The current consensus is Neutral. Of the 8 active firms as of Nov 19, 2026, 0 rate it Buy or Strong Buy, 7 rate it Neutral, and 1 rate it Sell or Strong Sell.
What are the highest and lowest price targets for TMHC?+
The Street-high target is $95.00, and the Street-low is $49.00 (Seaport Global). The average of all 6 active-firm targets is $71.67.
How many active Wall Street firms cover TMHC?+
8 active firms have a recognized rating on Taylor Morn Home as of Nov 19, 2026, and 6 active firms carry a live 12-month price target.
Who is the most accurate analyst covering TMHC?+
Among analysts who currently cover TMHC, Jay McCanless of Wedbush has the strongest overall Quantellect track record (Rank #13). Their current call is Buy with a $85.00 target.
What is Taylor Morn Home's projected EPS for next quarter?+
The consensus estimate is $1.42 per share (range $1.30 – $1.54) across 5 analysts. Full-year EPS is projected at $5.28, rising to $6.41 the following year.
How much revenue is Taylor Morn Home expected to report next quarter?+
Consensus revenue is $1.8B (range $1.6B – $1.9B). Full-year revenue is projected at $6.6B, growing to $7.2B next year.
Have analysts been upgrading or downgrading TMHC lately?+
As of Nov 19, 2026, 0 of 8 active firms rate TMHC a Buy (7 Neutral, 1 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their TMHC calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.